Adverse events in patients taking macrolide antibiotics versus placebo for any indication

Marlene Plejdrup Hansen, Sarah Thorning, Jeffrey K. Aronson, Elaine Mary Beller, Paul P Glasziou, Tammy C Hoffmann, Chris B Del Mar

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events inpatients taking macrolide antibiotics compared to placebo.
Original languageEnglish
Article numberCD011825
Pages (from-to)1-10
Number of pages10
JournalCochrane Database of Systematic Reviews
Volume2015
Issue number8
DOIs
Publication statusPublished - 14 Aug 2015

Fingerprint

Macrolides
Placebos
Anti-Bacterial Agents
Incidence
Inpatients
Bacteria

Cite this

@article{ac0c2fd9002a44e3bd266a688d46658e,
title = "Adverse events in patients taking macrolide antibiotics versus placebo for any indication",
abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events inpatients taking macrolide antibiotics compared to placebo.",
author = "Hansen, {Marlene Plejdrup} and Sarah Thorning and Aronson, {Jeffrey K.} and Beller, {Elaine Mary} and Glasziou, {Paul P} and Hoffmann, {Tammy C} and {Del Mar}, {Chris B}",
year = "2015",
month = "8",
day = "14",
doi = "10.1002/14651858.CD011825",
language = "English",
volume = "2015",
pages = "1--10",
journal = "Cochrane database of systematic reviews (Online)",
issn = "1469-493X",
publisher = "Wiley-Blackwell",
number = "8",

}

Adverse events in patients taking macrolide antibiotics versus placebo for any indication. / Hansen, Marlene Plejdrup; Thorning, Sarah; Aronson, Jeffrey K.; Beller, Elaine Mary; Glasziou, Paul P; Hoffmann, Tammy C; Del Mar, Chris B.

In: Cochrane Database of Systematic Reviews, Vol. 2015, No. 8, CD011825, 14.08.2015, p. 1-10.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Adverse events in patients taking macrolide antibiotics versus placebo for any indication

AU - Hansen, Marlene Plejdrup

AU - Thorning, Sarah

AU - Aronson, Jeffrey K.

AU - Beller, Elaine Mary

AU - Glasziou, Paul P

AU - Hoffmann, Tammy C

AU - Del Mar, Chris B

PY - 2015/8/14

Y1 - 2015/8/14

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events inpatients taking macrolide antibiotics compared to placebo.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events inpatients taking macrolide antibiotics compared to placebo.

UR - http://www.scopus.com/inward/record.url?scp=84997387417&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD011825

DO - 10.1002/14651858.CD011825

M3 - Article

VL - 2015

SP - 1

EP - 10

JO - Cochrane database of systematic reviews (Online)

JF - Cochrane database of systematic reviews (Online)

SN - 1469-493X

IS - 8

M1 - CD011825

ER -